Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!

Product Image
Product Description

Increase your productivity to 5 kg+ per day with the FlowSyn™ Maxi from Uniqsis!

The FlowSyn Maxi is a versatile and highly productive continuous flow reactor for high throughput single reactions with two reagents. With a flow rate of up to 80 ml/ min and the option to use Uniqsis’ high capacity (60 ml) coil reactor, the FlowSyn Maxi is the ideal scale-up tool for increasing your output to multi kg per day.

The high resolution FlowSyn user interface quickly guides you through the process of setting up your desired flow chemistry reactions. Once set up, the system automatically runs the experiment and cleans itself at the end of the program cycle. Comprehensive safety features, including automatic pressure regulation and over-pressure shut-down, ensure safe operation at all times.

With its key flowpath components made of stainless steel, the FlowSyn Maxi is a highly robust system capable of operating at 260°C, 1400 psi, and withstanding contact with corrosive fluids such as sulphuric and nitric acid. Other flowpath options (such as Hastelloy® and PTFE) are available for maximum chemical compatibility.

Uniqsis offers extensive “plug and play” options for temperature controlled static mixers and coil reactors, including the FlowSyn 60 ml coil reactor kit specifically designed for scale up.

The high-throughput FlowSyn Maxi can be expanded with the Uniqsis Binary Pump Module (BPM) to provide 4 reagent inputs and with other FlowSyn modules for automated multi-experiment and multi-step combinatorial capability. Optional cooling modules, with cooling capacities down to -88°C, are available for controlling highly exothermic reactions.

If you are looking at improving the output of your flow chemistry experiments, consider the FlowSyn Maxi from Uniqsis. Scale-up has never been easier!



Product FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!
Company Uniqsis
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

29 Station Road Shepreth Cambridgeshire SG8 6GB UK

Tel: +44 (0)845 864 7747


Scientific News
Inroads Against Leukemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Nanoparticles Can Make Medicines More Effective
Nanoparticles wrapped inside human platelet membranes serve as new vehicles for targeted drug delivery.
A Better Class of Cancer Drugs
An SDSU chemist has developed a technique to identify potential cancer drugs that are less likely to produce side effects.
Preventing Crystallization to Improve Drug Efficiency
Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos